Like SirT1, HO-1 confers protection in several vascular injury models, such us ischemic heart disease, atherosclerosis, hypertension, diabetes, or vascular proliferative diseases (Abraham and Kappas, 2005; Loboda et al., 2008; Kim et al., 2011). Here, SIRT1 is linked to diabetes mellitus.